Moreover, more than half of Fortune 500 pharmaceutical and medical device companies are operating under corporate integrity agreements (CIA) with the U.S. government to mitigate the risks.
Moreover, more than half of Fortune 500 pharmaceutical and medical device companies are operating under corporate integrity agreements (CIA) with the U.S. government to mitigate the risks.